Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Ferritins are ubiquitous proteins that function in iron storage and detoxification. Mammalian tissues that are metabolically highly active contain, in addition to the ubiquitous cytosolic ferritin, a ferritin that is localised to mitochondria. Mitochondrial ferritin (FtMt) functions to protect against oxidative stress and is found at higher levels in disease states that are associated with abnormal iron accumulation, such as Alzheimer’s and Parkinson’s. Here we demonstrate that, despite 80% sequence identity with cytosolic human H-chain ferritin, Fe 2+ oxidation at the catalytic diiron ferroxidase centre of FtMt proceeds via a distinct mechanism involving radical formation on a strictly conserved Tyr residue (Tyr34), and a mixed-valent ferroxidase centre (MVFC) that is readily detected under the O 2 -limiting conditions typical of mitochondria. Tyr34 is key for the activation of O 2 and stability of the MVFC. The highly unusual iron-O 2 chemistry exhibited by FtMt demonstrates that high levels of sequence identity between enzymes does not guarantee similarity of catalytic mechanism; here we explore the possible origin of the mechanistic differences between FtMt and cytosolic human H-chain ferritin.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.